The finished medicine is not reviewed the same way
As of September 26, 2026, compounded medicines reach patients without approval by FDA, the US Food and Drug Administration.
It does not check each preparation’s safety, benefit or quality before marketing.
When an approved product cannot meet a patient’s need, a medicine made to order can do so. That does not make every proposed ingredient available for compounding.
The ingredient question comes first
Federal rules do not permit just any raw ingredient in an ordinary pharmacy’s made-to-order drug, as checked on September 26, 2026.
An official ingredient quality standard sets written requirements for what the ingredient is and how pure it must be. If one exists, the pharmacy must meet it and the pharmacy preparation standards. Without an ingredient standard, the ingredient must be part of a medicine that has FDA approval. If neither applies, it must be on FDA’s list of extra ingredients allowed for ordinary pharmacy compounding.
FDA’s review checked September 28, 2026 found no official written quality standard for KPV and no FDA-approved medicine containing it.
At that check, KPV was not on the official list either.
Ask for the basis in writing
Ask what allows the pharmacy to use KPV. Request the ingredient’s full name and ask which pharmacy would prepare the medicine.
A pharmacy licence tells you about the pharmacy. It does not answer whether a raw ingredient meets the drug rules.
Check the pharmacy’s licence, ask what allows it to use KPV, and ask whether studies show help for your health problem. Each question needs an answer.